Fat-derived cells from adults with diffuse cutaneous scleroderma that are then injected under the skin of the hands led to clinically meaningful improvements in hand function, according to published data from the Phase 3 STAR I clinical trial.
Read the full article at sclerodermanews.com
Share:
Today can be the day you help a child whose life has been affected by scleroderma. Help us award one-time grants to children and grandchildren of those afflicted with systemic scleroderma.
As a nonprofit, we rely on donations to provide grants to kids whose lives have been affected by scleroderma. Together we will continue to care and continue to grow.